2nd Quarter - Report

LUNDBECK LLC for LUNDBECK LLC

A later version of this report replaces this one, so LegiList's totals use the current version instead. This page shows this version exactly as filed.

Firm
Client
Income
—
Expenses
$100,000
Expense method
A: Lobbying Disclosure Act definitions

Versions of this report

Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.

Filing Filed Amount Counted
2nd Quarter - Report (this page) Jul 19, 2023 $100,000 Replaced
2nd Quarter - Amendment Jul 19, 2023 $100,000 Yes

What was lobbied

3 issue areas, each in the filer's own words, with who lobbied on it and where.

Health Issues HCR

Issues regarding Pharmacy Benefit Managers Drug Affordability - H.R. 830, S. 1375 - The HELP Copays Act Step therapy reform - S. 6452 & H.R. 2630- The Safe Step Act Migraine care - Fiscal Year 2024 Military Construction, Veterans Affairs, and Related Agencies Funding Bill Neuroscience Drug Program - Fiscal Year 2024 Agriculture, Rural Development, Food and Drug Administration, and Related Agencies Funding Act R & D Tax Credit

LobbyistCovered position, as disclosed
HEATHER STRAWN —

Contacted: SENATE; HOUSE OF REPRESENTATIVES

Bills named: S. 1375 (118th), S. 6452 (118th), H.R. 830 (118th), H.R. 2630 (118th)

Medicare/Medicaid MMM

Issues pertaining to the 340B Drug Discount Program Issues pertaining to the implementation of the Inflation Reduction Act of 2022 Issues pertaining to Pharmacy Benefit Managers Issues pertaining to CMS Coverage of APS in LTC

LobbyistCovered position, as disclosed
HEATHER STRAWN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Taxation/Internal Revenue Code TAX

R & D tax credit

LobbyistCovered position, as disclosed
HEATHER STRAWN —

Contacted: HOUSE OF REPRESENTATIVES; SENATE

Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.